Pershing Square USA (NYSE:PSUS) Insider Purchases $201,250.00 in Stock

Pershing Square USA, Ltd. (NYSE:PSUS) insider Bruce Herring bought 5,000 shares of the stock in a transaction that occurred on Wednesday, June 17th. The shares were purchased at an average cost of $40.25 per share, for a total transaction of $201,250.00. Following the completion of the acquisition, the insider owned 15,000 shares of the company’s stock, valued at $603,750. This trade represents a 50.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Bruce Herring also recently made the following trade(s):

• On Thursday, April 30th, Bruce Herring acquired 10,000 shares of Pershing Square USA stock. The stock was acquired at an average cost of $43.41 per share, for a total transaction of $434,100.00.

Pershing Square USA Stock Down 1.6%

Shares of PSUS traded down $0.66 during mid-day trading on Wednesday, hitting $39.41. The company’s stock had a trading volume of 491,647 shares, compared to its average volume of 846,157. Pershing Square USA, Ltd. has a fifty-two week low of $37.15 and a fifty-two week high of $44.00.

Analyst Ratings Changes

Separately, Jefferies Financial Group initiated coverage on shares of Pershing Square USA in a research report on Monday, May 25th. They issued a “buy” rating on the stock. One analyst has rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy”.

Pershing Square USA, Inc (NYSE: PSUS) is a publicly traded investment company that provides investors with exposure to the investment strategies of Pershing Square Capital Management L.P., an investment adviser led by William A. Ackman. The company is listed on the New York Stock Exchange and functions as a vehicle through which shareholders can gain access to concentrated public equity investments managed by the Pershing Square team.

The firm’s main business activity is portfolio management: acquiring and holding equity positions in publicly traded companies with the objective of long‑term capital appreciation.